These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22831857)

  • 1. Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos).
    Tsai TH; Zhou C; Tao YK; Lee HC; Ahsen OO; Figueiredo M; Kirtane T; Adler DC; Schmitt JM; Huang Q; Fujimoto JG; Mashimo H
    Gastrointest Endosc; 2012 Dec; 76(6):1104-12. PubMed ID: 22831857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos).
    Zhou C; Tsai TH; Lee HC; Kirtane T; Figueiredo M; Tao YK; Ahsen OO; Adler DC; Schmitt JM; Huang Q; Fujimoto JG; Mashimo H
    Gastrointest Endosc; 2012 Jul; 76(1):32-40. PubMed ID: 22482920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.
    Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
    Gastrointest Endosc; 2012 Oct; 76(4):733-9. PubMed ID: 22732872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
    Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
    Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
    Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional optical coherence tomography of Barrett's esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation.
    Adler DC; Zhou C; Tsai TH; Lee HC; Becker L; Schmitt JM; Huang Q; Fujimoto JG; Mashimo H
    Endoscopy; 2009 Sep; 41(9):773-6. PubMed ID: 19746317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior endoscopic resection.
    Pouw RE; Visser M; Odze RD; Sondermeijer CM; ten Kate FJ; Weusten BL; Bergman JJ
    Endoscopy; 2014 Feb; 46(2):105-9. PubMed ID: 24285123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.
    Strauss AC; Agoston AT; Dulai PS; Srivastava A; Rothstein RI
    Surg Endosc; 2014 Dec; 28(12):3366-72. PubMed ID: 24950726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
    Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
    Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of buried Barrett's metaplasia in patients before and after radiofrequency ablation.
    Yuan J; Hernandez JC; Ratuapli SK; Ruff KC; De Petris G; Lam-Himlin DM; Burdick GE; Pannala R; Ramirez FC; Fleischer DE
    Endoscopy; 2012 Nov; 44(11):993-7. PubMed ID: 23108770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.
    Cotton CC; Wolf WA; Pasricha S; Li N; Madanick RD; Spacek MB; Ferrell K; Dellon ES; Shaheen NJ
    Gastrointest Endosc; 2015; 81(6):1362-9. PubMed ID: 25817897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
    Kaul V; Bittner K; Ullah A; Kothari S
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31909783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus.
    Shaheen NJ; Peery AF; Overholt BF; Lightdale CJ; Chak A; Wang KK; Hawes RH; Fleischer DE; Goldblum JR;
    Gastrointest Endosc; 2010 Sep; 72(3):490-496.e1. PubMed ID: 20598302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.